Discover

RGC
Regencell Bioscience Holdings Limited
5.94
1 x 5.61
1 x 6.05
bid
ask
-
0.12
1.98%
25 @ 03:59 PM
5.89 -0.05 (0.84%)
Ytd-71.71%
1y-56.55%
5.56
day range
6.20
4.92
52 week range
69.00
Open5.98Prev Close6.06Low5.56High6.20Mkt Cap2.50B
Vol270.59KAvg Vol274.77KEPS-0.01P/E-418.31Forward P/EN/A
Beta1.83Short Ratio3.30Inst. Own0.14%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning06-1550-d Avg18.98200-d Avg21.911yr Est0.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-06-152025-120-0.01N/AN/A
2025-11-182025-0600N/AN/A
2025-10-242026-100N/AN/AN/A
2025-06-262024-120-0.14N/AN/A
2024-10-252025-100N/AN/AN/A
2024-10-252024-060N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
Profile
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Geode Capital Management, LLC415.57K0.000.08%
2026-03-30Marex Group PLC31.60K0.000.01%
2026-03-30GSA Capital Partners LLP31.57K0.000.01%
2026-03-30Vident Advisory, LLC29.59K0.000.01%
2026-03-30Squarepoint Ops LLC26.61K0.000.01%
2026-03-30UBS Group AG23.89K0.000.00%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-04-29Fidelity Nasdaq Composite Index300.32K0.000.06%
2026-05-28Fidelity Nasdaq Composite ETF120.88K0.000.02%
2026-05-28L&G Asia Pacific ex Japan Equity ETF17.73K0.000.00%
2026-05-30CIBC US Broad Market Index15.29K0.000.00%
2026-05-28Amundi Prime Global ETF Dist10.55K0.000.00%
2026-05-30TD International Equity Index ETF9.60K0.000.00%
Dividend
DividendDate
8.362018-02-15
8.362017-12-01
8.362017-08-31
8.362017-06-01
8.362017-03-01
8.362016-12-01
Split
SplitDate
38 : 12025-06-16